臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yang c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 261-285 of 1273 (51 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-06-27T07:07:36Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:31Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:28Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:27Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:26Z	Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment	Chung K.-P.; Huang Y.-T.; Chang Y.-L.; CHONG-JEN YU; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:51Z	High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma	Yang C.-H.; Cheng A.-L.; Yeh K.-H.; CHONG-JEN YU; Lin J.-F.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:40Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	Kuo S.-H.; Yang C.-H.; CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:37Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:35Z	Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer	Shih J.-Y.; Gow C.-H.; CHONG-JEN YU; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:34Z	Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients	Chang G.-C.; Tsai C.-M.; Chen K.-C.; CHONG-JEN YU; Shih J.-Y.; Yang T.-Y.; Lin C.-P.; Hsu J.-Y.; Chiu C.-H.; Perng R.-P.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-06-27T07:06:33Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Yang C.-H.; Shih J.-Y.; Chen K.-C.; CHONG-JEN YU; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:32Z	Revisit of 1997 TNM staging system - Survival analysis of 1112 lung cancer patients in Taiwan	Perng R.-P.; Chen C.-Y.; Chang G.-C.; Hsia T.-C.; Hsu N.-Y.; Tsai Y.-H.; Tsai C.-M.; Yang C.-H.; Chen Y.-M.; CHONG-JEN YU; Lee J.-J.; Hsu H.-S.; Yu C.-T.; Kao E.-L.; Chiu C.-H.
臺大學術典藏	2022-06-27T07:06:31Z	A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma	Chen Y.-M.; CHONG-JEN YU; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; Cheng A.-L.; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:29Z	MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib	Bean J.; Brennan C.; Shih J.-Y.; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; Yang P.-C.; Miller V.; Ladanyi M.; Yang C.-H.; Pao W.
臺大學術典藏	2022-06-27T07:06:28Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:23Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chen J.-P.; Lo Y.; CHONG-JEN YU; Hsu C.; Shih J.-Y.; Yang C.-H.
臺大學術典藏	2022-06-27T07:06:22Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-06-27T07:06:21Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:20Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏	2022-06-27T07:02:07Z	Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors	Hsu C.-L.; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:58Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-10T06:11:16Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-06-10T06:11:15Z	High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy	Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y.

Showing items 261-285 of 1273 (51 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2856565
	???header.visitor??? : 53406675 ???header.onlineuser??? : 742 ???header.sponsordeclaration???